tiprankstipranks
Trending News
More News >
Tissue Regenix (GB:TRX)
:TRX
UK Market
Advertisement

Tissue Regenix (TRX) Financial Statements

Compare
14 Followers

Tissue Regenix Financial Overview

Tissue Regenix's market cap is currently £26.36M. The company's EPS TTM is p-0.005; its P/E ratio is ―; Tissue Regenix is scheduled to report earnings on June 25, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 28.65M$ 29.49M$ 19.87M$ 14.36M$ 12.83M
Gross Profit$ 13.62M$ 14.04M$ 9.14M$ 5.63M$ 5.13M
Operating Income$ 349.00K$ -394.00K$ -1.61M$ -2.98M$ -4.12M
EBITDA$ 1.36M$ 446.00K$ -690.87K$ -2.19M$ -9.03M
Net Income$ -713.00K$ -1.71M$ -2.19M$ -3.48M$ -9.71M
Balance Sheet
Cash & Short-Term Investments$ 1.87M$ 4.65M$ 4.95M$ 5.69M$ 9.55M
Total Assets$ 45.35M$ 43.24M$ 38.27M$ 34.13M$ 36.73M
Total Debt$ 10.46M$ 9.39M$ 7.99M$ 5.87M$ 5.32M
Net Debt$ 8.60M$ 4.75M$ 3.04M$ 175.72K$ -4.23M
Total Liabilities$ 16.29M$ 13.89M$ 13.00M$ 9.47M$ 8.88M
Stockholders' Equity$ 29.82M$ 30.15M$ 25.98M$ 25.35M$ 28.46M
Cash Flow
Free Cash Flow$ -5.70M$ 177.00K$ -2.29M$ -3.93M$ -6.84M
Operating Cash Flow$ -1.64M$ 1.04M$ -1.41M$ -2.45M$ -5.47M
Investing Cash Flow$ -4.06M$ -837.00K$ -884.90K$ -1.49M$ -1.37M
Financing Cash Flow$ 3.28M$ -1.51M$ 1.10M$ 144.69K$ 14.02M
Currency in USD

Tissue Regenix Earnings and Revenue History

Tissue Regenix Debt to Assets

Tissue Regenix Cash Flow

Tissue Regenix Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis